GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (FRA:2CV) » Definitions » EV-to-FCF

ConvaTec Group (FRA:2CV) EV-to-FCF : 29.91 (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ConvaTec Group's Enterprise Value is €7,069 Mil. ConvaTec Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €236 Mil. Therefore, ConvaTec Group's EV-to-FCF for today is 29.91.

The historical rank and industry rank for ConvaTec Group's EV-to-FCF or its related term are showing as below:

FRA:2CV' s EV-to-FCF Range Over the Past 10 Years
Min: 15.25   Med: 31   Max: 1056.92
Current: 28.7

During the past 11 years, the highest EV-to-FCF of ConvaTec Group was 1056.92. The lowest was 15.25. And the median was 31.00.

FRA:2CV's EV-to-FCF is ranked better than
50.27% of 374 companies
in the Medical Devices & Instruments industry
Industry Median: 28.735 vs FRA:2CV: 28.70

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), ConvaTec Group's stock price is €2.80. ConvaTec Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.068. Therefore, ConvaTec Group's PE Ratio (TTM) for today is 41.18.


ConvaTec Group EV-to-FCF Historical Data

The historical data trend for ConvaTec Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group EV-to-FCF Chart

ConvaTec Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.65 20.27 29.02 50.52 31.65

ConvaTec Group Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 50.52 - 31.65 -

Competitive Comparison of ConvaTec Group's EV-to-FCF

For the Medical Instruments & Supplies subindustry, ConvaTec Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ConvaTec Group's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ConvaTec Group's EV-to-FCF falls into.



ConvaTec Group EV-to-FCF Calculation

ConvaTec Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7068.958/236.312
=29.91

ConvaTec Group's current Enterprise Value is €7,069 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ConvaTec Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €236 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ConvaTec Group  (FRA:2CV) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ConvaTec Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.80/0.068
=41.18

ConvaTec Group's share price for today is €2.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ConvaTec Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.068.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ConvaTec Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ConvaTec Group Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, 7th Floor, Paddington, London, GBR, W2 6LG
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.

ConvaTec Group Headlines

No Headlines